Home › Kanser sa Pantog › North Carolina › Durham
Pag-aaral pangklinika para sa Kanser sa Pantog sa Durham, NC
Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Durham. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
The Vanguard Study: Testing a New Way to Screen for Cancer
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Nagre-recruitPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Durham VA Medical Center, Durham
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
- Duke University Medical Center (location of scans), Durham
- Duke University Medical Center - Duke University Hospital (location of scans), Durham
- Duke University Medical Center, Durham
- at 1 pa
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
Nagre-recruitPhase 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
- Research Site, Durham
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Nagre-recruitPhase 1
- Duke University Medical Center - Duke Cancer Center, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Nagre-recruitObservasyonal na pag-aaral
- UNC- Chapel Hill, Chapel Hill · 10 mi ang layo
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Nagre-recruitPhase 2
- University of North Carolina, Chapel Hill · 10 mi ang layo
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Nagre-recruitPhase 2/3
- Research Site, Chapel Hill · 10 mi ang layo
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi ang layo
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Nagre-recruitPhase 3
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 10 mi ang layo
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Nagre-recruitPhase 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 mi ang layo
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
Nagre-recruitObservasyonal na pag-aaral
- University of North Carolina, Chapel Hill · 10 mi ang layo
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Nagre-recruitPhase 2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · 10 mi ang layo
- UNC Lineberger Comprehensive Cancer Center / University of North Carolina, Chapel Hill · 10 mi ang layo
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
Nagre-recruit
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill · 10 mi ang layo
Characterizing the Microvascular Environment of Bladder Cancer With Super-Resolution Ultrasound Localization Microscopy
Nagre-recruitObservasyonal na pag-aaral
- Duke University, Durham
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Nagre-recruitPhase 1
- Duke Cancer Institute, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi ang layo
Pag-aaral para sa Kanser sa Pantog sa ibang lungsod
- New York City, NY35 pag-aaral
- Houston, TX31 pag-aaral
- Nashville, TN31 pag-aaral
- Dallas, TX27 pag-aaral
- Washington, DC26 pag-aaral
- Boston, MA26 pag-aaral
- Baltimore, MD24 pag-aaral
- Los Angeles, CA24 pag-aaral
- St. Louis, MO22 pag-aaral
- Seattle, WA21 pag-aaral
- Philadelphia, PA21 pag-aaral
- Chicago, IL21 pag-aaral
Iba pang pag-aaral sa Durham
- Kanser sa Suso64 pag-aaral
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer39 pag-aaral
- Multiple Myeloma37 pag-aaral
- Acute Myeloid Leukemia33 pag-aaral
- Metastatic Cancer33 pag-aaral
- Kanser sa Prostate32 pag-aaral
- Kanser sa Baga32 pag-aaral
- Colorectal Cancer28 pag-aaral
- Kanser sa Ovary27 pag-aaral
- Chronic Lymphocytic Leukemia27 pag-aaral
- Pagkabigo ng Puso26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.